Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects.
暂无分享,去创建一个
Caron | Reymond | Carrupt | Girault | Testa | H. Girault | P. Carrupt | V Girault | F. Reymond | Caron | Reymond | Testa | Bernard Testa | Giulia Caron
[1] N. Mandava,et al. Countercurrent chromatography : theory and practice , 1988 .
[2] P. Carrupt,et al. Structural Properties Governing Retention Mechanisms on RP-HPLC Stationary Phases Used for Lipophilicity Measurements , 1995 .
[3] Y. Sawada,et al. Prediction of therapeutic doses of beta-adrenergic receptor blocking agents based on quantitative structure-pharmacokinetic/pharmacodynamic relationship. , 1993, Biological & pharmaceutical bulletin.
[4] David E. Leahy,et al. Model Solvent Systems for QSAR Part I. Propylene Glycol Dipelargonate (PGDP). A new Standard Solvent for use in Partition Coefficient Determination , 1989 .
[5] A. Avdeef,et al. pH-metric log P. 4. Comparison of partition coefficients determined by HPLC and potentiometric methods to literature values. , 1994, Journal of pharmaceutical sciences.
[6] D. Minick,et al. Measurement of lipophilicity by high performance liquid chromatography comparison with calculated lipophilicity values , 1987 .
[7] A. Avdeef,et al. Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. , 1996, Journal of medicinal chemistry.
[8] N el Tayar,et al. Partitioning of solutes in different solvent systems: the contribution of hydrogen-bonding capacity and polarity. , 1991, Journal of pharmaceutical sciences.
[9] Alex Avdeef,et al. pH‐Metric log P. Part 1. Difference Plots for Determining Ion‐Pair Octanol‐Water Partition Coefficients of Multiprotic Substances , 1992 .
[10] Bernard Testa,et al. Lipophilicity Profiles of Ampholytes. , 1997, Chemical reviews.
[11] B Testa,et al. Esters of L‐Dopa: Structure‐hydrolysis Relationships and Ability to Induce Circling Behaviour in an Experimental Model of Hemiparkinsonism , 1995, The Journal of pharmacy and pharmacology.
[12] P. Carrupt,et al. Ionization and Partitioning Profiles of Zwitterions: The case of the anti‐inflammatory drug azapropazone , 1996 .
[13] M. Abraham,et al. On the partition of ampholytes: application to blood-brain distribution. , 1997, Journal of pharmaceutical sciences.
[14] Harpreet S. Chadha,et al. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. , 1994, Journal of pharmaceutical sciences.
[15] A. Y. Lu,et al. Role of pharmacokinetics and metabolism in drug discovery and development. , 1997, Pharmacological reviews.
[16] N el Tayar,et al. Percutaneous penetration of drugs: a quantitative structure-permeability relationship study. , 1991, Journal of pharmaceutical sciences.
[17] P. Carrupt,et al. Solvatochromic analysis of di-n-butyl ether/water partition coefficients as compared to other solvent systems , 1997 .
[18] A. Avdeef,et al. Bjerrum plots for the determination of systematic concentration errors in titration data , 1982 .
[19] Bernard Testa,et al. Solvatochromic Analysis of the Retention Mechanism of two Novel Stationary Phases Used for Measuring Lipophilicity by RP-HPLC , 1992 .
[20] H. Girault,et al. Cyclic voltammetry for the transfer of multiple charged ions at large ITIES: General computational methodology and application to simple and facilitated ion transfer reactions , 1997 .
[21] Bernard Testa,et al. Structure–lipophilicity relationships of zwitterionic amino acids , 1991 .
[22] Patrick Gaillard,et al. The conformation-dependent lipophilicity of morphine glucuronides as calculated from their molecular lipophilicity potential , 1994 .
[23] Han van de Waterbeemd,et al. Lipophilicity in drug action and toxicology , 1996 .
[24] D A Smith,et al. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics , 1996, Medicinal research reviews.
[25] H. Girault,et al. Mechanism of transfer of a basic drug across the water 1,2-dichloroethane interface: The case of quinidine , 1996 .
[26] K. Marsh,et al. Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption. , 1996, Journal of medicinal chemistry.
[27] M. L. La Rotonda,et al. Relationships between octanol-water partition data, chromatographic indices and their dependence on pH in a set of beta-adrenoceptor blocking agents. , 1990, Farmaco.
[28] A Pagliara,et al. Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist. , 1998, Journal of medicinal chemistry.
[29] P. Binkley,et al. Hemodynamic Responses to Indoramin at Rest and During Exercise in Congestive Heart Failure , 1987, Pharmacotherapy.
[30] J. Barré,et al. Comparative Pharmacokinetics of Intravenous Propranolol in Obese and Normal Volunteers , 1987, Journal of clinical pharmacology.
[31] Bernard Testa,et al. Intermolecular Forces Expressed in 1,2-Dichloroethane/Water Partition Coefficients: A Solvatochromic Analysis , 1997 .
[32] G. Zografi,et al. Oil-water partitioning of chlorpromazine and other phenothiazine derivatives using dodecane and n-octanol. , 1970, Journal of pharmaceutical sciences.
[33] H. Girault,et al. Charge and Delocalisation Effects on the Lipophilicity of Protonable Drugs , 1999 .
[34] Bernard Testa,et al. Lipophilicity Behavior of Model and Medicinal Compounds containing a suilfide, sulfoxide, or sulfone moiety , 1997 .
[35] D. Drayer. Lipophilicity, Hydrophilicity, and the Central Nervous System Side Effects of Beta Blockers , 1987, Pharmacotherapy.
[36] Harpreet S. Chadha,et al. Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning and the delta log P parameter of seiler. , 1994, Journal of pharmaceutical sciences.
[37] T. Koizumi,et al. Effect of pH on the skin permeability of a zwitterionic drug, cephalexin , 1995 .
[38] Michael H. Abraham,et al. Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes , 2010 .
[39] B. Testa,et al. Comparison of various non-polar stationary phases used for assessing lipophilicity , 1989 .
[40] P. Carrupt,et al. Intrinsic and intramolecular lipophilicity effects in O-glucuronides , 1998 .
[41] B. Testa,et al. Measurement of partition coefficients by various centrifugal partition chromatographic techniques : A comparative evaluation , 1991 .
[42] H. Girault,et al. Ionic Partition Diagrams: A Potential−pH Representation , 1996 .
[43] R Griffiths,et al. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.
[44] J. Topliss,et al. Unified model for the corneal permeability of related and diverse compounds with respect to their physicochemical properties. , 1996, Journal of pharmaceutical sciences.
[45] C. Lipinski,et al. Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocida. , 1997, Journal of medicinal chemistry.
[46] H. Kubinyi. QSAR : Hansch analysis and related approaches , 1993 .
[47] A. Hill,et al. Principles of method selection in partition studies , 1989 .
[48] K. Takács-Novák,et al. Interlaboratory study of log P determination by shake-flask and potentiometric methods. , 1996, Journal of pharmaceutical and biomedical analysis.
[49] T. Leemann,et al. The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro. , 1991, Life sciences.
[50] K. Takács-Novák,et al. Lipophilicity of amphoteric molecules expressed by the true partition coefficient , 1995 .
[51] John C. Dearden,et al. The Measurement of Partition Coefficients , 1988 .
[52] H. Girault,et al. Effects of charge and intramolecular structure on the lipophilicity of nitrophenols , 1999 .